(Note: For PDF File Swipe To The End Of Article)
Category: Obstetrics and Gynecology | Medical Education | Nursing | Maternal Health
1. Introduction: When Pregnancy Becomes a Medical Challenge
Pregnancy is often described as one of the most beautiful experiences in a person's life. During this period, the mother's body undergoes remarkable changes to support the growth and development of a baby. The heart works harder, blood volume increases, hormones change, and the placenta develops to provide oxygen and nutrients to the growing fetus.
However, pregnancy can sometimes be complicated by conditions that threaten the health of both mother and baby. One of the most important of these conditions is pre-eclampsia.
Pre-eclampsia is a pregnancy-related disorder characterized by newly developed high blood pressure after 20 weeks of pregnancy, accompanied by protein in the urine and/or evidence of damage to organs or other pregnancy-related complications. It can affect the kidneys, liver, brain, blood vessels, lungs, placenta, and other systems.
What makes pre-eclampsia particularly dangerous is that it may develop quietly. A pregnant woman may feel relatively well while her blood pressure rises and important organs begin to show signs of stress. In other cases, the condition produces severe headaches, visual disturbances, upper abdominal pain, breathing difficulties, or other warning signs.
Without timely recognition and appropriate treatment, pre-eclampsia can progress to serious complications, including eclampsia, HELLP syndrome, stroke, kidney injury, placental abruption, premature birth, and, in severe cases, maternal or fetal death.
The condition is not the mother's fault. It is not simply caused by worrying too much, eating the wrong food, or failing to rest. Its development involves complex biological changes related to placental development, blood vessels, and the body's response to pregnancy.
The encouraging news is that regular antenatal care, early diagnosis, careful monitoring, appropriate medicines, and timely delivery can substantially reduce the risk of serious outcomes.
This article explains pre-eclampsia in detail, from its definition and underlying mechanisms to risk factors, symptoms, diagnosis, treatment, nursing management, prevention, postpartum care, and long-term health implications.
2. What Is Pre-Eclampsia?
Pre-eclampsia is a multisystem disorder associated with pregnancy. It usually develops after 20 weeks of gestation, although it can occasionally appear earlier in unusual circumstances. It can also first develop after childbirth.
The condition is primarily identified by new-onset hypertension during pregnancy together with proteinuria or other evidence of maternal organ dysfunction or uteroplacental complications.
Hypertension means abnormally high blood pressure. Proteinuria means an excessive amount of protein in the urine.
The presence of protein in the urine is an important diagnostic finding, but it is not essential in every case. A pregnant woman may have pre-eclampsia without proteinuria if high blood pressure is accompanied by qualifying signs of organ dysfunction.
Pre-eclampsia can range from a condition that remains stable under close monitoring to a rapidly worsening emergency.
Some patients have few symptoms and are diagnosed during routine antenatal appointments. Others develop severe hypertension, persistent headache, visual problems, abdominal pain, or evidence of impaired kidney or liver function.
The timing of diagnosis, severity of the condition, gestational age, fetal growth, and response to treatment all influence management.
Pre-eclampsia is not simply a temporary blood pressure problem. It is a complex pregnancy disorder that can affect multiple organ systems and may have consequences for both immediate and future health.
3. Why Is Pre-Eclampsia Called a Silent Threat?
Pre-eclampsia is sometimes described as a silent threat because early disease may not produce noticeable symptoms.
A pregnant woman may feel normal even when her blood pressure is elevated. Protein in the urine and abnormalities in blood tests may also develop without obvious warning signs.
This makes routine antenatal screening essential.
Blood pressure measurement allows healthcare professionals to identify hypertension before the patient necessarily feels unwell. Urine testing and blood investigations can help detect additional evidence of disease.
However, screening cannot replace awareness of symptoms. Pre-eclampsia may worsen between appointments, and a patient who develops new warning signs needs assessment even if her most recent checkup was normal.
The most important principle is simple: a pregnant woman does not need to feel seriously ill for pre-eclampsia to be present.
Likewise, severe symptoms should never be dismissed merely because a previous blood pressure reading was normal.
4. Anatomy and Physiology: Understanding the Placenta
To understand pre-eclampsia, it is necessary to understand the placenta and its blood supply.
4.1 What is the placenta?
The placenta is an organ that develops during pregnancy. It provides oxygen and nutrients to the fetus, removes fetal waste products, and produces hormones that support pregnancy.
Maternal blood flows through spaces within the placenta, allowing exchange of substances between maternal and fetal circulations without normally mixing the two blood supplies directly.
The placenta depends on an adequate supply of maternal blood.
4.2 Uterine arteries
The uterus receives blood through uterine arteries, which branch into smaller vessels supplying the uterine wall and placenta.
During a healthy pregnancy, specialized placental cells called trophoblasts participate in remodeling the maternal spiral arteries.
This remodeling helps transform the arteries into vessels capable of supplying a large volume of blood to the developing placenta at relatively low resistance.
4.3 Normal placental development
In a healthy pregnancy, placental development establishes an efficient blood supply that meets the growing fetus's needs.
The mother's cardiovascular system also adapts to pregnancy through changes in blood volume, cardiac output, vascular resistance, and hormonal regulation.
These changes normally support maternal health and fetal growth.
4.4 What may go wrong in pre-eclampsia?
In many cases of pre-eclampsia, placental development and the remodeling of maternal blood vessels do not occur normally.
The placenta may receive an inadequate or poorly regulated blood supply. This can contribute to the release of substances that affect the mother's blood vessels and vascular lining.
The resulting widespread endothelial dysfunction helps explain why pre-eclampsia can affect the kidneys, liver, brain, lungs, blood clotting system, and placenta.
Not every case follows precisely the same biological pathway, and researchers continue to investigate the mechanisms that make some pregnancies more vulnerable than others.
5. Pathophysiology: How Does Pre-Eclampsia Develop?
Pre-eclampsia is a complex disorder rather than a single isolated problem.
Step 1: Abnormal placental development
In many affected pregnancies, placental development involves incomplete remodeling of maternal spiral arteries.
The arteries may remain narrower and more resistant than expected, limiting the placenta's ability to receive blood efficiently.
Step 2: Placental stress
The altered blood supply can contribute to placental stress and changes in the release of biological signaling molecules.
These changes may become more pronounced as pregnancy progresses.
Step 3: Release of circulating factors
The placenta may release substances that disrupt normal blood vessel function.
One important area of research involves an imbalance between factors that promote blood vessel growth and factors that inhibit it. For example, changes involving placental growth factor and soluble fms-like tyrosine kinase-1 have been associated with pre-eclampsia.
These substances are part of a larger network of biological processes and do not explain every case independently.
Step 4: Endothelial dysfunction
The endothelium is the inner lining of blood vessels.
When endothelial function becomes impaired, blood vessels may constrict abnormally, become more permeable, and regulate clotting and inflammation less effectively.
These changes contribute to elevated blood pressure and reduced blood flow to certain tissues.
Step 5: Maternal organ involvement
The effects of abnormal vascular function may appear in different organs.
- Kidneys: Protein may leak into the urine, and kidney function may deteriorate.
- Liver: Liver enzymes may rise, and upper abdominal pain may occur.
- Brain: Severe headache, visual disturbance, stroke, or seizures may develop.
- Lungs: Fluid may accumulate in the lungs, causing breathing difficulty.
- Blood and clotting system: Platelet counts may fall, and severe cases may involve abnormal clotting or HELLP syndrome.
- Placenta: Reduced placental function may restrict fetal growth or contribute to medically indicated premature delivery.
Step 6: Clinical disease becomes apparent
The condition may be detected through elevated blood pressure, urine abnormalities, blood test results, fetal growth concerns, or symptoms.
The timing and severity vary between individuals.
Important: Pre-eclampsia is not caused by one simple factor. Placental development, maternal susceptibility, vascular function, immune mechanisms, and other biological processes all appear to contribute.
6. Causes and Risk Factors of Pre-Eclampsia
The exact cause of pre-eclampsia is not fully understood. It is thought to arise through interactions between placental development and maternal biological factors.
Certain conditions increase risk, but pre-eclampsia can occur even when a woman has no obvious risk factors.
6.1 First pregnancy
Pre-eclampsia is more common in a first pregnancy than in many subsequent pregnancies.
However, having a previous healthy pregnancy does not eliminate the possibility of developing the condition later.
6.2 Previous pre-eclampsia
A history of pre-eclampsia, particularly early-onset or severe disease, increases the risk of recurrence.
The risk depends on factors such as the severity and timing of the previous episode, current medical conditions, and the interval between pregnancies.
A history of pre-eclampsia should be discussed during pre-pregnancy counseling and early antenatal care.
6.3 Chronic hypertension
Chronic hypertension is high blood pressure that exists before pregnancy or is identified early enough to be considered pre-existing.
It increases the risk of developing pre-eclampsia and can make diagnosis more challenging because blood pressure may already be elevated.
Close monitoring helps identify changes that suggest superimposed pre-eclampsia.
6.4 Kidney disease
Chronic kidney disease can increase pre-eclampsia risk.
It can also complicate diagnosis because proteinuria and abnormal kidney function may already be present before pregnancy.
Baseline measurements and specialist follow-up can help clinicians identify important changes.
6.5 Diabetes mellitus
Type 1 and type 2 diabetes are associated with increased risk.
Pregnancy-related diabetes management, blood pressure monitoring, and assessment of maternal and fetal health are important parts of care.
6.6 Multiple pregnancy
Pregnancy with twins, triplets, or more than one fetus increases the risk of pre-eclampsia.
Multiple pregnancies also have other complications that may influence the timing and planning of delivery.
6.7 Autoimmune disorders
Certain autoimmune conditions, including systemic lupus erythematosus and antiphospholipid syndrome, are associated with increased risk.
These conditions can affect blood vessels, clotting, kidney function, and placental health.
6.8 Family history
A mother, sister, or other close relative with pre-eclampsia may indicate an increased risk.
Both genetic and environmental influences may contribute to this association.
6.9 Maternal age
Older maternal age is associated with increased risk in many clinical guidelines, particularly when other risk factors are present.
Age alone does not determine whether pre-eclampsia will develop.
6.10 Obesity
A higher pre-pregnancy body mass index is associated with increased risk.
Weight is only one part of the overall risk assessment, and pre-eclampsia should never be treated as a personal failure or blamed on an individual's body size.
6.11 Long interval between pregnancies
A long interval between pregnancies may increase risk in some individuals.
The significance depends on the complete clinical history and other risk factors.
6.12 Assisted reproduction
Some pregnancies achieved through assisted reproductive technologies may have an increased risk, depending on the circumstances.
The overall risk should be interpreted in the context of maternal age, multiple pregnancy, underlying infertility factors, and other medical conditions.
6.13 No identifiable risk factors
A woman can develop pre-eclampsia without any recognized risk factors.
For this reason, regular antenatal monitoring remains important for every pregnancy.
7. Types and Clinical Forms of Pre-Eclampsia
Pre-eclampsia can be described according to its timing, severity, and associated clinical features.
7.1 Early-onset pre-eclampsia
Early-onset pre-eclampsia generally refers to disease developing before 34 weeks of pregnancy.
It is more likely to be associated with significant placental dysfunction and fetal growth restriction, although outcomes vary.
Management can be challenging because the medical team must balance the risks of continuing pregnancy against the risks of premature birth.
7.2 Late-onset pre-eclampsia
Late-onset disease develops at or after 34 weeks.
It may occur closer to the expected date of delivery, but it can still cause severe maternal complications and may require urgent delivery.
7.3 Pre-eclampsia without severe features
This describes pre-eclampsia without the severe blood pressure levels or other severe clinical features used in diagnostic guidelines.
Even when severe features are absent, the condition requires monitoring because it may worsen.
7.4 Pre-eclampsia with severe features
Severe features may include:
- Systolic blood pressure of 160 mm Hg or higher or diastolic pressure of 110 mm Hg or higher.
- Severe or persistent headache not explained by another condition.
- Visual disturbances.
- Significant impairment of kidney function.
- Abnormally elevated liver enzymes with concerning symptoms or findings.
- Low platelet count.
- Pulmonary edema.
- Persistent severe pain in the upper abdomen or under the right ribs.
These findings require urgent assessment and appropriate management.
7.5 Superimposed pre-eclampsia
Superimposed pre-eclampsia develops when a pregnant woman with chronic hypertension develops additional findings consistent with pre-eclampsia.
These may include new proteinuria, worsening hypertension, maternal organ dysfunction, or other relevant clinical changes.
Diagnosis can be difficult when hypertension or kidney disease existed before pregnancy, making careful comparison with baseline findings essential.
7.6 Postpartum pre-eclampsia
Pre-eclampsia can develop after childbirth, including in women who had normal blood pressure during pregnancy.
It commonly presents in the first several days after delivery but may occur during the following weeks.
Postpartum pre-eclampsia is particularly important because families may assume that delivery has eliminated all pregnancy-related risks.
8. Signs and Symptoms of Pre-Eclampsia
Symptoms vary. Some women have no noticeable symptoms, while others develop warning signs that require immediate medical assessment.
8.1 High blood pressure
High blood pressure is a central feature of pre-eclampsia.
A reading of 140/90 mm Hg or higher after 20 weeks of pregnancy is an important threshold for evaluation. The diagnosis depends on the clinical context and appropriate confirmation.
Severe-range blood pressure—160 mm Hg systolic or 110 mm Hg diastolic or higher—is an emergency that requires prompt clinical management.
High blood pressure often does not cause symptoms, so regular measurements are essential.
8.2 Protein in the urine
Proteinuria occurs when more protein than expected passes from the blood into the urine.
It may be detected through a urine protein-to-creatinine ratio, albumin-related testing, or a 24-hour urine collection, depending on local protocols.
Proteinuria supports the diagnosis, but its absence does not rule out pre-eclampsia when other qualifying features are present.
8.3 Severe or persistent headache
A new headache that is severe, persistent, or different from usual headaches may be a warning sign.
It is particularly concerning when accompanied by visual changes, high blood pressure, upper abdominal pain, or feeling seriously unwell.
A severe headache should not be dismissed as ordinary pregnancy discomfort without assessment.
8.4 Visual disturbances
Visual symptoms may include:
- Blurred vision.
- Seeing flashing lights.
- Spots or dark areas in the visual field.
- Temporary loss of vision.
- Unusual sensitivity to light.
These symptoms may indicate involvement of the nervous system and require urgent assessment.
8.5 Upper abdominal pain
Pain under the right ribs or in the upper abdomen can occur when pre-eclampsia affects the liver.
Some people describe it as persistent pressure, aching, or pain that does not improve with usual measures.
Upper abdominal pain may also have other causes, but in pregnancy it should be evaluated promptly when pre-eclampsia is possible.
8.6 Sudden swelling
Swelling of the face and hands, especially when it develops suddenly, can be concerning.
However, swelling of the feet and ankles is also common in normal pregnancy. Swelling alone cannot diagnose pre-eclampsia.
The pattern of swelling and the presence of other symptoms should guide assessment.
8.7 Rapid weight gain
A sudden increase in weight may reflect fluid retention.
However, weight gain varies during pregnancy and is not a reliable diagnostic test on its own.
A rapid change accompanied by swelling, headache, high blood pressure, or breathing difficulties deserves medical assessment.
8.8 Nausea and vomiting
Nausea and vomiting are common in early pregnancy, but new or worsening symptoms in the second half of pregnancy may be concerning when accompanied by other warning signs.
Persistent vomiting or feeling severely unwell should not automatically be attributed to normal pregnancy changes.
8.9 Shortness of breath
Breathing difficulty may occur if fluid accumulates in the lungs, a serious complication called pulmonary edema.
New or severe breathlessness, chest pain, or difficulty breathing at rest requires urgent medical attention.
8.10 Reduced fetal movement
A noticeable reduction in the baby's usual movement pattern can indicate a problem requiring assessment.
Reduced fetal movement does not specifically diagnose pre-eclampsia, but it must not be ignored.
8.11 Reduced urine output
A marked decrease in urine output may indicate dehydration, kidney dysfunction, or another serious problem.
In a patient with suspected pre-eclampsia, reduced urine output needs prompt clinical evaluation.
9. Warning Signs That Require Immediate Medical Attention
Pre-eclampsia can become life-threatening. Anyone who is pregnant or has recently given birth should seek urgent medical assessment for symptoms such as:
- Severe or persistent headache.
- Blurred vision, flashing lights, or other sudden visual changes.
- Severe pain under the ribs or in the upper abdomen.
- Difficulty breathing or chest pain.
- Seizure or loss of consciousness.
- Severe-range blood pressure, if measured.
- Sudden severe illness, confusion, or collapse.
- A significant reduction in the baby's usual movements.
A seizure during pregnancy or after childbirth is an emergency.
Do not wait for every symptom to appear, and do not delay seeking care to repeat a home blood pressure measurement if severe symptoms are present.
10. How Is Pre-Eclampsia Diagnosed?
Diagnosis combines blood pressure measurements, urine testing, blood investigations, clinical symptoms, and assessment of fetal well-being.
10.1 Blood pressure measurement
Blood pressure should be measured using an appropriate device and cuff size, with the patient positioned correctly.
A reading of 140/90 mm Hg or higher after 20 weeks of pregnancy raises concern for hypertension.
The clinical team may repeat the measurement according to the circumstances and applicable guidelines.
Severe-range blood pressure requires urgent management; treatment should not be dangerously delayed while waiting for routine confirmation procedures.
10.2 Urine protein testing
Urine testing assesses whether protein is present in amounts consistent with proteinuria.
Common approaches include:
- Urine protein-to-creatinine ratio.
- Albumin-to-creatinine ratio, where appropriate.
- A 24-hour urine protein collection.
- Urine dipstick testing when quantitative methods are unavailable or as part of initial assessment.
A 24-hour urine collection may be useful in some situations, but it is not necessary for every patient.
10.3 Complete blood count and platelet count
A complete blood count can help identify a low platelet count or other blood abnormalities.
Platelets are important for normal blood clotting. A falling platelet count may indicate more severe disease or HELLP syndrome.
10.4 Liver function tests
Blood tests may measure liver enzymes such as AST and ALT.
Elevated liver enzymes can indicate liver involvement. When accompanied by severe upper abdominal pain or other findings, they may suggest severe pre-eclampsia.
10.5 Kidney function tests
Serum creatinine and other appropriate tests help assess kidney function.
A rise in creatinine can indicate impaired kidney function, although interpretation must account for pregnancy-related changes and any pre-existing kidney disease.
10.6 Assessment of symptoms
The clinician will ask about headache, vision, upper abdominal pain, breathing difficulty, nausea, swelling, and changes in general well-being.
A physical examination and review of the medical history help determine severity and identify other possible diagnoses.
10.7 Fetal ultrasound
Ultrasound may be used to assess fetal growth, amniotic fluid volume, and other relevant features.
Because pre-eclampsia can affect placental function, the baby may grow more slowly than expected.
10.8 Fetal heart-rate monitoring
Depending on gestational age and clinical circumstances, fetal heart-rate monitoring may help assess the baby's condition.
Additional monitoring may be needed when fetal growth restriction or other concerns are present.
10.9 Doppler studies
Doppler ultrasound can assess blood flow in selected fetal and placental vessels.
It may be used when fetal growth restriction or placental insufficiency is suspected.
10.10 Angiogenic biomarkers
In some healthcare settings, tests involving placental growth factor or the sFlt-1/PlGF ratio can help assess the likelihood of pre-eclampsia in selected patients.
These tests are adjuncts to clinical assessment, not universal replacements for blood pressure measurement, laboratory investigations, and clinical judgment. Availability and recommended use vary.
11. Diagnostic Criteria: What Healthcare Professionals Look For
Pre-eclampsia is generally suspected when new hypertension develops after 20 weeks of pregnancy.
The commonly used blood pressure threshold is:
- Systolic pressure of at least 140 mm Hg, and/or
- Diastolic pressure of at least 90 mm Hg.
The hypertension is accompanied by one or more of the following, depending on the applicable guideline:
- Proteinuria.
- New kidney dysfunction.
- Liver dysfunction.
- Low platelet count.
- Pulmonary edema.
- New neurological symptoms or visual disturbances.
- Other recognized evidence of maternal organ involvement or uteroplacental dysfunction.
The precise diagnostic framework varies somewhat between guidelines, and the clinician must consider alternative explanations.
A patient can have pre-eclampsia without proteinuria. Conversely, protein in the urine alone does not establish pre-eclampsia without the appropriate clinical context.
Clinical point: Diagnosis should not depend on one laboratory result in isolation. The overall pattern of blood pressure, symptoms, organ function, gestational age, and fetal assessment matters.
12. Differential Diagnosis: Conditions That Can Resemble Pre-Eclampsia
Several conditions may cause hypertension, headache, abdominal pain, or abnormal laboratory findings during pregnancy.
12.1 Gestational hypertension
Gestational hypertension is new-onset hypertension after 20 weeks without the defining additional features of pre-eclampsia at the time of assessment.
It can progress to pre-eclampsia, so ongoing monitoring is necessary.
12.2 Chronic hypertension
Chronic hypertension exists before pregnancy or is identified early in pregnancy.
A woman with chronic hypertension may later develop superimposed pre-eclampsia.
12.3 Migraine and other headache disorders
Migraine and other headache conditions can cause severe pain or visual symptoms.
However, a new or unusually severe headache during pregnancy must be assessed carefully because pre-eclampsia and other emergencies may produce similar symptoms.
12.4 Kidney disease
Kidney disorders can cause hypertension and proteinuria.
Comparison with baseline kidney function, urine findings, symptoms, and other investigations helps clarify the diagnosis.
12.5 Liver and gallbladder conditions
Gallstones, hepatitis, and other liver disorders can cause upper abdominal pain or abnormal liver enzymes.
These conditions may need to be distinguished from pre-eclampsia and HELLP syndrome.
12.6 Thrombotic microangiopathies and other blood disorders
Certain uncommon disorders can cause low platelets, hemolysis, and organ dysfunction, sometimes resembling severe pre-eclampsia or HELLP syndrome.
Specialist assessment and targeted investigations may be needed.
13. Complications of Pre-Eclampsia in the Mother
Pre-eclampsia can affect several organ systems. The risk of complications depends on disease severity, gestational age, the presence of underlying medical conditions, and the timeliness of treatment.
13.1 Eclampsia
Eclampsia is the occurrence of seizures associated with pre-eclampsia when another cause does not better explain them.
Seizures can occur before delivery, during labor, or after childbirth.
Eclampsia is a medical emergency requiring stabilization, seizure treatment, blood pressure management, and assessment of the need for delivery.
13.2 Stroke
Severe hypertension can damage blood vessels in the brain and increase the risk of stroke.
Stroke may cause sudden weakness, difficulty speaking, severe headache, visual changes, or loss of consciousness.
Any suspected stroke requires emergency care.
13.3 HELLP syndrome
HELLP syndrome is a serious complication characterized by:
- H: Hemolysis, or breakdown of red blood cells.
- EL: Elevated liver enzymes.
- LP: Low platelet count.
It can cause upper abdominal pain, nausea, vomiting, weakness, and other symptoms. Some patients may not initially have the classic signs of pre-eclampsia.
HELLP syndrome requires urgent specialist care because it can progress rapidly.
13.4 Acute kidney injury
Reduced kidney perfusion and other disease-related changes can impair kidney function.
Severe cases may cause a significant rise in creatinine and reduced urine output.
13.5 Liver injury
Liver involvement may cause elevated enzymes, upper abdominal pain, and, in rare severe cases, bleeding or liver complications.
Persistent right upper abdominal pain in a patient with suspected pre-eclampsia requires urgent assessment.
13.6 Pulmonary edema
Pulmonary edema is the accumulation of fluid in the lungs.
It can cause severe breathlessness, low oxygen levels, and respiratory distress.
Treatment requires urgent medical care and careful management of fluids and cardiovascular function.
13.7 Disseminated intravascular coagulation
Disseminated intravascular coagulation, or DIC, is a serious disorder in which the clotting system becomes abnormally activated and may eventually cause bleeding.
It can occur in association with severe obstetric complications, including HELLP syndrome, placental abruption, or other critical illness.
13.8 Placental abruption
Placental abruption occurs when the placenta separates from the uterine wall before the baby is born.
It can cause vaginal bleeding, abdominal pain, uterine tenderness, fetal distress, or maternal instability. Bleeding may not always be visible externally.
13.9 Maternal death
Severe pre-eclampsia and its complications can be fatal if not recognized and treated promptly.
Early detection, access to emergency obstetric care, appropriate medication, and timely delivery are essential to reducing this risk.
14. Complications for the Baby
Pre-eclampsia can affect the fetus because the placenta is responsible for supplying oxygen and nutrients.
14.1 Fetal growth restriction
Reduced or abnormal placental blood flow can limit fetal growth.
A baby may be smaller than expected for gestational age, although not every small baby has growth restriction caused by pre-eclampsia.
Ultrasound assessment and other fetal monitoring help guide management.
14.2 Premature birth
Delivery may need to occur before the expected due date to protect the mother's health or the baby's well-being.
Premature babies have a greater risk of breathing difficulties, feeding problems, temperature instability, and other complications. The degree of risk depends partly on how early birth occurs and the resources available for neonatal care.
14.3 Low birth weight
A baby may have low birth weight because of premature delivery, restricted growth, or both.
Some babies require additional monitoring or support after birth.
14.4 Reduced oxygen supply
Placental dysfunction can affect the delivery of oxygen to the fetus.
Fetal monitoring helps clinicians identify concerning changes and determine whether earlier delivery is necessary.
14.5 Stillbirth
Severe placental dysfunction and other complications can increase the risk of fetal death before birth.
Although this is not the outcome for most pregnancies receiving appropriate care, it is one reason careful monitoring and timely intervention are so important.
14.6 Long-term effects of prematurity
Some babies born very prematurely may experience ongoing developmental, respiratory, vision, hearing, or other health problems.
Neonatal care and follow-up can help identify and manage these needs.
15. Treatment of Pre-Eclampsia
Treatment aims to protect the mother, reduce the risk of severe complications, monitor fetal well-being, and determine the safest time for delivery.
The treatment plan depends on gestational age, blood pressure, symptoms, laboratory findings, fetal growth, and whether severe features are present.
There is currently no treatment that reliably removes the underlying placental process while pregnancy continues. Delivery of the placenta is the definitive treatment, but the timing must be carefully planned.
15.1 Maternal stabilization
When pre-eclampsia is severe, the immediate priorities are to stabilize the mother and reduce the risk of complications.
This may involve blood pressure treatment, seizure prevention, monitoring of oxygen levels and urine output, laboratory investigations, and assessment of the fetus.
In an emergency, maternal stabilization takes priority while the obstetric team plans the next steps.
15.2 Antihypertensive medicines
Medicines are used to lower dangerously high blood pressure and reduce the risk of stroke and other complications.
Commonly used medicines in pregnancy include labetalol, nifedipine, and hydralazine, depending on the situation and local protocols.
Severe-range hypertension requires urgent treatment. The specific medicine and route depend on the patient's condition, contraindications, and available resources.
Blood pressure control does not eliminate pre-eclampsia, but it is an essential part of reducing maternal risk.
15.3 Magnesium sulfate
Magnesium sulfate is commonly used to prevent or treat seizures in patients with severe pre-eclampsia or eclampsia when indicated.
It is an anticonvulsant medication, not primarily a blood pressure-lowering drug.
Administration requires clinical monitoring because excessive magnesium can cause toxicity. Monitoring may include breathing, reflexes, urine output, and other findings according to the treatment protocol.
15.4 Corticosteroids for fetal maturation
If premature delivery is anticipated, corticosteroids may be administered to help accelerate fetal lung maturation and reduce certain complications of prematurity.
The decision depends on gestational age and the clinical situation.
Corticosteroids should not delay a medically necessary emergency delivery.
15.5 Fluid management
Careful fluid management is important because severe pre-eclampsia can increase the risk of pulmonary edema.
Both inadequate circulation and excessive fluid administration can be harmful. Intravenous fluids should therefore be individualized and monitored.
15.6 Maternal and fetal monitoring
Monitoring may include repeated blood pressure measurements, symptom assessment, blood tests, urine output, fetal heart-rate monitoring, and ultrasound.
The frequency and setting of monitoring depend on disease severity and clinical stability.
15.7 Delivery planning
The timing of delivery is one of the most important decisions in pre-eclampsia care.
Delivery is generally recommended at 37 weeks for pre-eclampsia without severe features if the condition remains stable, while severe pre-eclampsia often requires delivery at or after 34 weeks once the mother has been stabilized.
Earlier delivery may be necessary at any gestational age if the mother's or baby's condition deteriorates. In selected stable cases before 34 weeks, specialist teams may consider closely monitored expectant management in an appropriate hospital setting.
The decision must balance the risks of continuing pregnancy against those of premature birth.
15.8 Vaginal delivery or cesarean birth
Pre-eclampsia does not automatically mean that a cesarean section is necessary.
Induction of labor and vaginal birth may be appropriate when maternal and fetal conditions allow.
Cesarean birth may be recommended for obstetric reasons, fetal compromise, the need for rapid delivery, or other clinical considerations.
The safest method depends on the individual circumstances.
16. Management According to Gestational Age
The stage of pregnancy strongly influences the management plan.
16.1 Before 34 weeks
If pre-eclampsia develops early, the baby may benefit from additional time for growth and maturation.
However, continuing pregnancy also exposes the mother and fetus to ongoing risk.
In selected stable cases, specialist teams may consider expectant management in hospital with close maternal and fetal surveillance. This may include blood pressure treatment, magnesium sulfate when indicated, and corticosteroids if premature delivery is anticipated.
Expectant management is not appropriate when serious maternal or fetal deterioration requires delivery.
16.2 Between 34 and 36 weeks and 6 days
For pre-eclampsia with severe features, delivery is generally recommended after maternal stabilization at or beyond 34 weeks, unless specific circumstances require a different approach.
For patients without severe features, the care team weighs maternal and fetal findings and usually plans delivery by 37 weeks if the condition remains stable.
The plan may change if symptoms, blood pressure, laboratory results, or fetal monitoring become concerning.
16.3 At 37 weeks or later
Delivery is generally recommended for diagnosed pre-eclampsia at this stage because the risks of continuing pregnancy may outweigh the benefits of waiting.
The obstetric team will determine whether induction or cesarean birth is appropriate.
16.4 Emergency delivery
At any gestational age, serious maternal or fetal deterioration may require urgent delivery.
Examples include uncontrolled severe hypertension, eclampsia, significant organ dysfunction, placental abruption, pulmonary edema, or evidence of serious fetal compromise.
The immediate clinical priority is to reduce the risk of life-threatening harm.
17. Can Pre-Eclampsia Be Prevented?
There is no guaranteed way to prevent every case of pre-eclampsia. However, identifying risk factors and following evidence-based preventive strategies can reduce risk in selected patients.
17.1 Early antenatal care
Booking an antenatal appointment early in pregnancy allows healthcare professionals to review medical history, assess risk factors, measure blood pressure, and plan appropriate follow-up.
Early care is especially important for women with chronic hypertension, kidney disease, diabetes, autoimmune disorders, or a previous history of pre-eclampsia.
17.2 Low-dose aspirin
Low-dose aspirin may reduce the risk of pre-eclampsia in pregnant people identified as being at increased risk.
Professional guidelines recommend considering it for eligible patients, with the starting time and dose determined according to the applicable guideline and clinical circumstances.
Do not start aspirin during pregnancy on your own. A qualified healthcare professional should assess whether it is appropriate, when it should begin, and when it should stop.
17.3 Calcium supplementation
Calcium supplementation may reduce the risk of pre-eclampsia in populations where dietary calcium intake is low.
Recommendations depend on local dietary patterns, clinical guidance, and individual circumstances.
Calcium supplements should be taken according to professional advice rather than as a substitute for antenatal care.
17.4 Control of pre-existing medical conditions
Before and during pregnancy, appropriate management of hypertension, diabetes, kidney disease, and other chronic conditions can improve maternal health and support safer pregnancy care.
Medication choices may need adjustment before conception or during pregnancy.
17.5 Healthy lifestyle practices
A balanced diet, appropriate physical activity when medically permitted, and management of pre-existing conditions support overall health.
These measures cannot guarantee prevention, and pre-eclampsia should never be blamed on an individual's behavior alone.
17.6 Regular blood pressure checks
Blood pressure should be measured during antenatal visits according to recommended care schedules.
Patients who are advised to monitor blood pressure at home should receive clear instructions about the device, measurement technique, recording results, and when to seek help.
17.7 Awareness of symptoms
Knowing the warning signs allows a pregnant woman and her family to seek help when symptoms arise between appointments.
Education is an important part of prevention of severe complications, even though it does not eliminate the biological risk of developing pre-eclampsia.
.jpeg)
